Recent Company News

• 07:13 AM ET Apr 29, 2025
  

  Travere Therapeutics expects to receive $17.5M milestone payment from CSL Vifor following standard EU approval of FILSPARI for IgA nephropathy ($19.36, 0.00)

• 06:14 AM ET Apr 29, 2025
  

  EU Commission offers 17 countries the possibility to purchase over 27M influenza vaccine doses

• 02:08 AM ET Apr 29, 2025
  

  European Commission converts conditional approval of FILSPARI into standard marketing authorization for treatment of IgA Nephropathy (A$245.13, 0.00)

• 02:01 AM ET Apr 29, 2025
  

  CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy

• 10:53 AM ET Apr 25, 2025
  

  EU's CHMP adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Zoonotic Influenza Vaccine Seqirus (A$241.89, 0.00)

• 10:29 AM ET Apr 25, 2025
  

  EMA CHMP publishes summary of opinions for April meeting

• 01:02 AM ET Apr 11, 2025
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (38 total)

• 09:51 PM ET Apr 10, 2025
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 12:53 AM ET Apr 09, 2025
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (52 total)

• 10:02 PM ET Apr 08, 2025
  

  Follow-up: US President Donald Trump says the US will unveil "major" tariff on imports of pharmaceutical goods - NBC News